BacTech Mining Corporation

BacTech Mining Corporation

January 12, 2007 09:35 ET

BacTech Issues Options

TORONTO, ONTARIO--(CCNMatthews - Jan. 12, 2007) - BacTech Mining Corporation ("BacTech" or the "Company") (TSX VENTURE:BM) today announced that the Board of Directors has approved the issuance of 150,000 options to purchase common shares of the Company to Director Peter George. The exercise price is $.15 and the term is 5 years. The total number of outstanding options under the Company's plan is 3,185,000 or approximately 6.12% of the outstanding shares.

BacTech continues to pursue opportunities where its technology can add value to specific projects.


BacTech has developed and patented bacterial oxidation technology for the treatment of refractory ores and concentrates to enhance the recovery of gold, silver and base metals. BacTech has successfully commissioned three bioleach plants for gold and demonstrated its technology in the selective recovery of base metals from complex sulphide concentrates in a joint project with Industrias Penoles de C.V. of Mexico. The Company's focus is the acquisition of equity positions in projects amenable to bioleaching.

Shares outstanding 52,006,134

The TSX Venture Exchange has not reviewed and does not accept any responsibility for the adequacy or accuracy of this release.

Contact Information